Long Ge Selected Research

ansuvimab

9/2022

Effects of therapies for Ebola virus disease: a systematic review and network meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Long Ge Research Topics

Disease

11	COVID-19 01/2022 - 01/2020
5	Pain (Aches) 01/2022 - 11/2015
5	Hemorrhage 05/2021 - 01/2018
5	Infections 01/2021 - 01/2016
5	Neoplasms (Cancer) 10/2019 - 11/2016
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2022 - 01/2014
4	Weight Loss (Weight Reduction) 01/2022 - 01/2018
4	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2014
4	Critical Illness (Critically Ill) 05/2021 - 01/2019
3	Nausea 01/2022 - 01/2014
3	Tuberculosis (Tuberculoses) 11/2020 - 11/2014
3	Pancreatic Neoplasms (Pancreatic Cancer) 10/2019 - 12/2017
3	Postoperative Pain 05/2019 - 11/2015
3	Type 2 Diabetes Mellitus (MODY) 03/2019 - 01/2019
2	Ulcer 03/2022 - 01/2020
2	Cancer Pain 01/2022 - 10/2021
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022 - 01/2022
2	Vomiting 01/2022 - 01/2014
2	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 05/2021
2	Hypotension (Low Blood Pressure) 05/2021 - 05/2019
2	Fever (Fevers) 01/2021 - 01/2020
2	Sepsis (Septicemia) 01/2020 - 01/2016
2	Bronchopulmonary Dysplasia 01/2020 - 11/2018
2	Body Weight (Weight, Body) 01/2020 - 03/2019
2	Birth Weight (Birth Weights) 01/2020 - 11/2018
2	Postoperative Nausea and Vomiting (PONV) 05/2019 - 01/2019
2	Heart Failure 03/2018 - 02/2018
2	Catheter-Related Infections 04/2017 - 01/2016
2	Febrile Neutropenia 01/2017 - 01/2014
1	Ebola Hemorrhagic Fever 09/2022
1	Dysbiosis 06/2022
1	Pressure Ulcer (Bedsore) 03/2022
1	Wounds and Injuries (Trauma) 03/2022
1	Arthralgia (Joint Pain) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Obesity 01/2022
1	Cognitive Dysfunction 01/2022
1	Overweight 01/2022
1	Delirium 01/2022
1	Cardiotoxicity 01/2022
1	Epilepsy (Aura) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 08/2021
1	Neoplasm Metastasis (Metastasis) 08/2021

Drug/Important Bio-Agent (IBA)

4	remdesivirIBA 09/2022 - 01/2020
3	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022 - 01/2020
3	Pharmaceutical PreparationsIBA 01/2021 - 01/2018
3	Janus Kinase InhibitorsIBA 01/2021 - 01/2020
3	Proton Pump InhibitorsIBA 11/2020 - 01/2018
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 11/2018
2	salicylhydroxamic acid (SHAM)IBA 03/2022 - 01/2017
2	Analgesics (Analgesic Drugs)IBA 01/2022 - 01/2019
2	Opioid Analgesics (Opioids)IBA 01/2022 - 01/2019
2	Lopinavir FDA Link 01/2022 - 01/2020
2	Ritonavir (Norvir)FDA Link 01/2022 - 01/2020
2	sotrovimabIBA 01/2021 - 01/2020
2	Ivermectin (Mectizan)FDA Link 01/2021 - 01/2020
2	Janus KinasesIBA 01/2021 - 01/2020
2	casirivimab and imdevimab drug combinationIBA 01/2021 - 01/2020
2	Monoclonal AntibodiesIBA 01/2021 - 01/2020
2	Sucralfate (Carafate)FDA LinkGeneric 11/2020 - 01/2020
2	molnupiravirIBA 01/2020 - 01/2020
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2020 - 01/2020
2	HDL CholesterolIBA 01/2020 - 02/2019
2	nirmatrelvir and ritonavir drug combinationIBA 01/2020 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 09/2019 - 12/2017
2	MicroRNAs (MicroRNA)IBA 11/2018 - 12/2017
2	Polysaccharides (Glycans)IBA 09/2015 - 01/2014
1	ZMappIBA 09/2022
1	atoltivimab, maftivimab, and odesivimab-ebgn drug combinationIBA 09/2022
1	ansuvimabIBA 09/2022
1	2,2',4,4'-tetrabromodiphenyl etherIBA 06/2022
1	Aromatase InhibitorsIBA 01/2022
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022
1	Topiramate (Topamax)FDA LinkGeneric 01/2022
1	Phentermine (Adipex-P)FDA LinkGeneric 01/2022
1	Polymethyl Methacrylate (Sol)IBA 01/2022
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2022
1	semaglutideIBA 01/2022
1	Capsules (Microcapsules)IBA 12/2021
1	arginyl- threonyl- prolyl- prolyl- prolyl- seryl- glycine (SP 6)IBA 10/2021

Therapy/Procedure

12	Therapeutics 09/2022 - 01/2017
5	Injections 03/2018 - 01/2014
4	Drug Therapy (Chemotherapy) 01/2022 - 08/2017
4	Radiotherapy 01/2021 - 09/2015
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 10/2021 - 09/2015
3	Length of Stay 01/2021 - 11/2015
2	Chemoradiotherapy 12/2022 - 07/2019
2	Renal Dialysis (Hemodialysis) 05/2021 - 04/2017
2	Fat-Restricted Diet (Diet, Fat Restricted) 01/2020 - 02/2019
2	Artificial Respiration (Mechanical Ventilation) 01/2020 - 01/2019
2	Mediterranean Diet 01/2020 - 02/2019
2	Adjuvant Chemotherapy 10/2019 - 02/2019
2	Glycemic Control 02/2019 - 01/2018
1	Acupressure (Shiatsu) 01/2022
1	Ketogenic Diet 01/2022
1	Gastrectomy 01/2022
1	Acupuncture Therapy 10/2021
1	Acupuncture Points (Acupuncture Point) 10/2021
1	Neoadjuvant Therapy 08/2021